Patient attitudes toward detection of heterozygous familial hypercholesterolaemia;Patienters holdning til opsporing af arvelig sygdom: Heterozygot familiœr hyperkolesterolœmi

Ugeskrift for Laeger

Volumn 160, Issue 42, 1998, Pages 6075-6081

  Andersen, Lone K ^a   Jensen, Henrik K ^b   Juul, Svend ^b   Fœrgeman, Ole ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CORONARY ARTERY DISEASE; DENMARK; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HEART MUSCLE ISCHEMIA; HETEROZYGOTE DETECTION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; ATTITUDE TO HEALTH; CORONARY DISEASE; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUESTIONNAIRES;

EID: 0032511658     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hubbard R, Lewontin RC. Pitfalls of genetic testing. N Engl J Med 1996; 334: 1192-4.
2. Whitelaw S, Northover JM, Hodgson SV. Attitudes to predictive DNA testing in familial adenomatous polyposis. J Med Genet 1996; 33: 540-3.
3. Gustavson KH. The prevention and management of autosomal recessive conditions. Main example: alpha 1-antitrypsin deficiency. Clin Genet 1989, 36: 327-32.
4. Konsensusrapport. Kolesterol og iskæmisk hjertesygdom, København: Statens Lægevidenskabelige Forskningsråd og Dansk Sygehus Institut, 1986.
5. Dehlholm B, Færgeman O. Psykologiske og sociale konsekvenser ved positivt testresultat ved screeningsundersøgelser for cardiovaskulære sygdomme. Manedsskr Prakt Lægegern 1988; 66: 759-64.
6. Meissen GJ, Berchek RL. Intentions to use predictive testing by those at risk for Huntington's disease: implications for prevention. Am J Community Psychol 1988; 16: 261-77.
7. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995; 57: 385-92.
8. Hietala M, Hakonen A, Aro AR, Niemela P, Peltonen L, Aula P. Attitudes toward genetic testing among the general population and relatives of patients with a severe genetic disease: a survey from Finland. Am J Hum Genet 1995; 56: 1493-500.
9. Codori AM, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease. Am J Med Genet 1994; 54: 167-73.
10. Van der Steenstraten IM, Tibben A, Roos RA, van de Kamp JJ, Niermeijer MF. Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet 1994; 55: 618-25.
11. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. I: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1995, 1981-2030
12. Hansen PS, Norgaard Petersen B, Meinertz H, Jensen HK, Hansen AB, Klausen IC et al. Incidence of the apolipoprotein B-3500 mutation in Denmark. Clin Chim Acta 1994; 230: 101-4.
13. Jensen HK, Hansen PS, Jensen LG, Kristensen MJ, Klausen IC, Kjeldsen M et al. Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease. Clin Genet 1995; 48: 23-8.
14. Jensen J, Blankenhorn DH, Kornerup V. Coronary disease in familial hypercholesterolemia. Circulation 1967; 36: 77-82.
15. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hyper-cholesterolaemia. BMJ 1991; 303. 893-6.
16. Hansen PS, Solling J, Knudsen TE, Færgeman O. Ikke-diætetisk, ikke-farmakologisk behandling af svær hyperkolesterolæmi. Ugeskr Læger 1991; 153: 2046-51.
17. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007-12.
18. Jensen HK, Jensen TG, Jensen LG, Hansen PS, Kjeldsen M, Andersen BS et al. Characterization of a disease-causing Glu 119-Lys mutation in the low-density lipoprotein receptor gene in two Danish families with heterozygous familial hypercholesterolemia. Hum Mutat 1994; 4: 102-13.
19. Andersen LK, Jensen HK, Juul S, Færgeman O. Patient attitudes to detection of heterozygous familial hypercholesterolemia. Arch Intern Med 1997; 157: 553-60.
20. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer Breast Cancer Res Treat 1993; 28, 145-55.